Jinling Pharmaceutical Company Limited (SHE:000919)
China flag China · Delayed Price · Currency is CNY
8.58
-0.33 (-3.70%)
Apr 9, 2026, 3:04 PM CST

SHE:000919 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
1,5171,7711,5481,4951,502
Short-Term Investments
-165.22337.45250-
Trading Asset Securities
939.31706.05233.8692.351.25
Cash & Short-Term Investments
2,4562,6422,1191,8371,503
Cash Growth
-7.03%24.69%15.33%22.25%14.12%
Accounts Receivable
690.95686.73591.05467.22507.2
Other Receivables
5.428.168.7653.1216.85
Receivables
696.38694.89599.81520.34524.05
Inventory
233.14271.62290.91250.48245.48
Prepaid Expenses
--0.151.16-
Other Current Assets
411.919.379.6323.7916.29
Total Current Assets
3,7983,6183,0202,6332,289
Property, Plant & Equipment
1,4571,5011,5411,3031,297
Long-Term Investments
62.37431.07369.32265.01638.97
Goodwill
44.3762.42148.7227.3318.05
Other Intangible Assets
322.93325.67341.67258.44140.2
Long-Term Deferred Tax Assets
12.6112.4916.6128.5419.62
Long-Term Deferred Charges
120.5583.3413.9418.2617.85
Other Long-Term Assets
189.1954.494210.726.96
Total Assets
6,0076,0895,4934,5444,448
Accounts Payable
554.97595.31546.69454.04479.36
Accrued Expenses
98.2212.46224.73219.95207.27
Short-Term Debt
---1.4815.01
Current Portion of Long-Term Debt
8.74----
Current Portion of Leases
-4.233.081.531.06
Current Income Taxes Payable
58.6235.5337.9748.3843.09
Current Unearned Revenue
19.5735.617.6522.1426.9
Other Current Liabilities
235.85143.9182.53117.983.25
Total Current Liabilities
975.951,0271,013865.42855.95
Long-Term Debt
150.1150.12---
Long-Term Leases
32.9834.8538.62.290.59
Long-Term Unearned Revenue
0.6810.470.630.79
Long-Term Deferred Tax Liabilities
25.0127.2828.7248.9855.77
Total Liabilities
1,1851,2401,080917.32913.1
Common Stock
621.92623.71511.14510.4504
Additional Paid-In Capital
1,0881,098651.74478.34462.06
Retained Earnings
2,0652,0732,0952,0251,958
Treasury Stock
--6.77-26.99-23.62-
Comprehensive Income & Other
2.663.093.424.173.29
Total Common Equity
3,7783,7913,2342,9942,928
Minority Interest
1,0441,0571,178632.88606.84
Shareholders' Equity
4,8224,8494,4123,6273,535
Total Liabilities & Equity
6,0076,0895,4934,5444,448
Total Debt
191.82189.2141.675.316.66
Net Cash (Debt)
2,2652,4532,0771,8321,486
Net Cash Growth
-7.68%18.08%13.39%23.26%12.85%
Net Cash Per Share
3.644.144.123.642.95
Filing Date Shares Outstanding
622.06623.71629.06488.88510.4
Total Common Shares Outstanding
622.06623.71511.14488.88504
Working Capital
2,8222,5912,0071,7681,433
Book Value Per Share
6.076.086.336.125.81
Tangible Book Value
3,4103,4032,7442,7082,769
Tangible Book Value Per Share
5.485.465.375.545.50
Buildings
-1,4951,5071,2941,274
Machinery
-1,4161,3491,1141,074
Construction In Progress
-71.7884.237.8428.78
Source: S&P Global Market Intelligence. Standard template. Financial Sources.